← Back to headlines
Jim Cramer Endorses Rigel Pharmaceuticals as a Speculative Buy
Jim Cramer has expressed a positive outlook on Rigel Pharmaceuticals, suggesting it is performing better than generally perceived and recommending it as a speculative investment.
27 Mar, 18:01 — 27 Mar, 18:01
Sources
Showing 1 of 1 sources
Related Stories
Marcos Jr. Pledges New Hospitals for Military Veterans in Visayas and Mindanao
just now
Madrid Hospital's Pediatric Cardiac Surgery Team Performs 'Marathon' of Three Surgeries in 24 Hours
20m ago
Nigerian Research Institute Staff Declare Indefinite Strike Over Retirement Dispute
24m ago
WHO Warns of Impending Pandemic, Strengthens Global Health Network
43m ago